The U.S. Food and Drug Administration (U.S. FDA) has issued four observations to Gland Pharma’s formulation facility near Hyderabad. The four Form 483 observations followed an unannounced inspection on current…
- Sunday, October 25, 2026
The U.S. Food and Drug Administration (U.S. FDA) has issued four observations to Gland Pharma’s formulation facility near Hyderabad. The four Form 483 observations followed an unannounced inspection on current…